AJN in October: Oral Treatments for Breast Cancer, PAD in Older Adults, Research or Not Research, More
The October issue of AJN is now live. Here are some articles we’d like to bring to your attention.
CE Feature: “A Review of Common Oral Treatments for Breast Cancer: Improving Patient Safety in Nononcology Settings”
According to the National Cancer Institute, more than 3 million women in the United States are currently living with a breast cancer diagnosis. Many seek care in nononcology settings for treatment, acute symptoms and complaints related to their cancer diagnosis, or unrelated concerns. Yet many nononcology providers are unfamiliar with the various oral agents used to treat breast cancer and their possible adverse effects and drug interactions. This article provides an overview of the most common oral treatments for breast cancer and discusses common adverse effects and management.
In the acute care setting, pain, agitation, and delirium (PAD) often occur as interrelated parts of a syndrome rather than as separate entities. Because the three facets of PAD may be similar in presentation, it is often difficult for clinicians to recognize the syndrome and to assess and treat it. The challenge is particularly great in older patients. This article provides an overview of each aspect of PAD, discusses clinical considerations related to the assessment and treatment of the syndrome in older adults receiving acute care, and illustrates the application of published PAD guidelines.
Perspectives on Palliative Nursing: “For Advanced Cancer, What Treatment is Next?”
This second installment in a series on palliative care developed in collaboration with the Hospice and Palliative Nurses Association, discusses how nurses can best serve patients faced with the choice between aggressive treatments and palliative or hospice care.